<DOC>
	<DOC>NCT00646711</DOC>
	<brief_summary>To assess the tolerability of switching from Depakote Sprinkle Capsules or Depakote tablets to Depakote ER tablets in the pediatric population.</brief_summary>
	<brief_title>Pediatric Switch Study for Children and Adolescent Patients With Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Male or female patient with a clinical diagnosis of epilepsy considered stable by the investigator. Must be in good physical health, on the same dose of all medications, including Depakote and other AEDs, for 2 week period prior to randomization. Minimum body weight of 37 lbs. Sixmonth history of drug or alcohol abuse. Status epilepticus within 6 months prior to screening. Abnormal platelet or ALT/AST levels.</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>